RP9 pseudogene (RP9P)

RP9 pseudogene (RP9P) is a DNA sequence similar to the functional RP9 gene, but rendered non-functional by mutations or truncations. It is classified as a non-processed pseudogene, located in tandem array near the real RP9 gene. Rare gene conversion events can transfer mutations from RP9P to the active RP9 gene, producing a form of autosomal dominant retinitis pigmentosa (adRP). RP9P itself does not encode a functional protein and is not expressed as a molecular target. Pseudogenes like RP9P are increasingly recognized for potential roles as regulatory elements or biomarkers in cancer, but RP9P has not been proven to play such roles directly. RP9 pseudogene (RP9P) is not a therapeutic target, receptor, or enzyme. It is a non-coding DNA segment, whose disease relevance is indirect—via gene conversion events that may create pathogenic mutations in the parental RP9 gene, especially retinitis pigmentosa. No drugs, mechanisms of action, or biomarkers are established for RP9P itself. If compiling structured data, this entry should be flagged as not a target and potentially problematic due to nomenclature and functional ambiguity.

Other names

RP9P

None. As a non-coding pseudogene, RP9P cannot be directly targeted by drugs. Where gene conversion occurs (rare), the functional RP9 gene may acquire pathogenic mutations, but this is not a mechanism amenable to pharmacological targeting.